SCHEMBL3402945

SCHEMBL3402945

NC(=O)c1c2ccccc2nc2cccc(CC(=O)O)c12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.51
KDM4E B2RXH2 4/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 2/20 0.41
POLB P06746 2/20 0.41
AKR1B1 P15121 1/20 0.41
GLA P06280 2/20 0.41
PLA2G2A P14555 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
PDE10A Q9Y233 2/20 0.38
CYP2C9 P11712 1/20 0.38
HPGD P15428 1/20 0.38
CYP2C19 P33261 1/20 0.38
DUSP3 P51452 1/20 0.37
PTPN5 P54829 1/20 0.37
PTPN11 Q06124 1/20 0.37
CTDSP1 Q9GZU7 1/20 0.37
MAPK8 P45983 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7470977 0.86 TDP1 (0.51) TDP1KDM4EMEN1KMT2AALDH1A1
SCHEMBL10697117 0.82 MAPT (0.42) MEN1KMT2ASMN1; SMN2MAPT
SCHEMBL3406646 0.81 DYRK1A (0.45) TDP1KDM4EALDH1A1POLBPLA2G2A
SCHEMBL8168011 0.78 PDE10A (0.47) MEN1KMT2AALDH1A1PDE10AHPGD
SCHEMBL30148539 0.78 HSD17B10 (0.52) TDP1KDM4EKMT2AALDH1A1LMNA
SCHEMBL61597 0.78 HSD17B10 (0.52) TDP1KDM4EKMT2AALDH1A1LMNA
SCHEMBL9330379 0.74 PDE10A (0.44) KDM4EMEN1KMT2ALMNAPOLB
SCHEMBL3402941 0.74 AKR1B1 (0.47) KDM4EMEN1KMT2AALDH1A1LMNA
SCHEMBL9424812 0.74 PARP1 (0.46) TDP1MEN1KMT2ALMNAPOLB
SCHEMBL1420726 0.73 CDK9 (0.39) TDP1KDM4EMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100129800-A1 POLYMERS AND THEIR USE AS FLUORESCENT LABELS AYMAMI BOFARULL JUAN 2010-05-27 US disclosed
WO-2009007397-A1 NEW POLYMERS AND THEIR USE AS FLUORESCENT LABELS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2009-01-15 WO disclosed
EP-2014698-A1 Polymers and their use as fluorescent labels Crystax Pharmaceuticals S.L. (ES) 2009-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100129800-A1 POLYMERS AND THEIR USE AS FLUORESCENT LABELS CBR3, H1-0, H1-3 TDP1 3387/4885KDM4E 3889/4885MEN1 1726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.